| 1XU7 | A:; C:; D:; B: | CRYSTAL STRUCTURE OF THE INTERFACE OPEN CONFORMATION OF TETRAMERIC 11B-HSD1 |
| 1XU9 | A:; B:; C:; D: | CRYSTAL STRUCTURE OF THE INTERFACE CLOSED CONFORMATION OF 11B-HYDROXYSTEROID DEHYDROGENASE ISOZYME 1 |
| 2BEL | A:; B:; C:; D: | STRUCTURE OF HUMAN 11-BETA-HYDROXYSTEROID DEHYDROGENASE IN COMPLEX WITH NADP AND CARBENOXOLONE |
| 2ILT | A: | HUMAN 11-BETA-HYDROXYSTEROID DEHYDROGENASE (HSD1) WITH NADP AND ADAMANTANE SULFONE INHIBITOR |
| 2IRW | A:; B:; C:; D:; E:; F:; G:; H: | HUMAN 11-BETA-HYDROXYSTEROID DEHYDROGENASE (HSD1) WITH NADP AND ADAMANTANE ETHER INHIBITOR |
| 2RBE | A:; B:; C:; D: | THE DISCOVERY OF 2-ANILINOTHIAZOLONES AS 11BETA-HSD1 INHIBITORS |
| 3BYZ | A:; B:; C:; D: | 2-AMINO-1,3-THIAZOL-4(5H)-ONES AS POTENT AND SELECTIVE 11-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS |
| 3BZU | A:; B:; C:; D: | CRYSTAL STRUCTURE OF HUMAN 11-BETA-HYDROXYSTEROID DEHYDROGENASE(HSD1) IN COMPLEX WITH NADP AND THIAZOLONE INHIBITOR |
| 3CH6 | A:; B:; D:; E: | CRYSTAL STRUCTURE OF 11BETA-HSD1 DOUBLE MUTANT (L262R, F278E) COMPLEXED WITH (3,3-DIMETHYLPIPERIDIN-1-YL)(6-(3-FLUORO-4-METHYLPHENYL)PYRIDIN-2-YL)METHANONE |
| 3CZR | A:; B: | CRYSTAL STRUCTURE OF HUMAN 11-BETA-HYDROXYSTEROID DEHYDROGENASE (HSD1) IN COMPLEX WITH ARYLSULFONYLPIPERAZINE INHIBITOR |
| 3D3E | A:; B:; C:; D: | CRYSTAL STRUCTURE OF HUMAN 11-BETA-HYDROXYSTEROID DEHYDROGENASE (HSD1) IN COMPLEX WITH BENZAMIDE INHIBITOR |
| 3D4N | A:; B:; C:; D: | CRYSTAL STRUCTURE OF HUMAN 11-BETA-HYDROXYSTEROID DEHYDROGENASE (HSD1) IN COMPLEX WITH SULFONAMIDE INHIBITOR |
| 3D5Q | A:; B:; C:; D: | CRYSTAL STRUCTURE OF 11B-HSD1 IN COMPLEX WITH TRIAZOLE INHIBITOR |
| 3EY4 | A:; B:; C:; D: | FURTHER STUDIES WITH THE 2-AMINO-1,3-THIAZOL-4(5H)-ONE CLASS OF 11-HYDROXYSTEROID DEHYDROGENASE TYPE 1 (11-HSD1) INHIBITORS: REDUCING PREGNANE X RECEPTOR (PXR) ACTIVITY AND EXPLORING ACTIVITY IN A MONKEY PHARMACODYNAMIC MODEL |
| 3FCO | A:; B: | CRYSTAL STRUCTURE OF 11BETA-HYDROXYSTEROID DEHYDROGENASE 1 (11B-HSD1) IN COMPLEX WITH BENZAMIDE INHIBITOR |
| 3FRJ | A:; B: | CRYSTAL STRUCTURE OF 11B-HYDROXYSTEROID DEHYDROGENASE-1 (11B-HSD1) IN COMPLEX WITH PIPERIDYL BENZAMIDE INHIBITOR |
| 3H6K | A:; B:; C:; D: | CRYSTAL STRUCTURE OF HUMAN 11-BETA-HYDROXYSTEROID-DEHYDROGENASE BOUND TO AN ORTHO-CHLRO-SULFONYL-PIPERAZINE INHIBITOR |
| 3HFG | A:; B:; C:; D: | CRYSTAL STRUCTURE OF HUMAN 11-BETA-HYDROXYSTEROID-DEHYDROGENASE BOUND TO AN SULFONYL-PIPERAZINE INHIBITOR |
| 3OQ1 | A:; B:; C:; D: | CRYSTAL STRUCTURE OF 11BETA-HYDROXYSTEROID DEHYDROGENASE-1 (11B-HSD1) IN COMPLEX WITH DIARYLSULFONE INHIBITOR |
| 3PDJ | A:; B: | CRYSTAL STRUCTURE OF HUMAN 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 (11B-HSD1) IN COMPLEX WITH 4,4-DISUBSTITUTED CYCLOHEXYLBENZAMIDE INHIBITOR |
| 3QQP | A:; B:; C:; D: | CRYSTAL STRUCTURE OF 11BETA-HYDROXYSTEROID DEHYDROGENASE 1 (11B-HSD1) IN COMPLEX WITH UREA INHIBITOR |
| 3TFQ | A:; B:; D:; E: | CRYSTAL STRUCTURE OF 11B-HSD1 DOUBLE MUTANT (L262R, F278E) COMPLEXED WITH 8-{[(2-CYANOPYRIDIN-3-YL)METHYL]SULFANYL}-6-HYDROXY-3,4-DIHYDRO-1H-PYRANO[3,4-C]PYRIDINE-5-CARBONITRILE |
| 4HFR | A:; B: | HUMAN 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 IN COMPLEX WITH AN ORALLY BIOAVAILABLE ACIDIC INHIBITOR AZD4017. |
| 4HX5 | A:; B:; C:; D: | CRYSTAL STRUCTURE OF 11 BETA-HSD1 IN COMPLEX WITH SAR184841 |
| 4K1L | A:; B:; C:; D: | 4,4-DIOXO-5,6-DIHYDRO-[1,4,3]OXATHIAZINES, A NOVEL CLASS OF 11 BETA-HSD1 INHIBITORS FOR THE TREATMENT OF DIABETES |
)
)